Staphylococcal
pleuropulmonary disease (SPP) is the localization of pathogenic staphylococcal
disease in the lung and pleura and its general haematogenic consequences. This
location is not primary, but follows a primary skin or mucous infection that
may go unnoticed. This is a very rare phenomenon in neonatology and in the
various literature reviews. Through our observation we report
the clinical diagnosis of a newborn 13-day age with pleuro-pulmonary
staphyloccocia point of departure cutaneous, thus the paraclinical explorations performed in our patient therapeutic
management and evolutionary profile after a 3-month decline. Note that
the problem of resistance of staphylococci to different antibiotics is
currently a real public health problem making the choice of treatment very
difficult for the clinician.
References
[1]
Qbaron, D., Drugeon, H.B. and Touze, M.D. (1987) Le Staphylocoque en 1987. Maladies Infectieuses, 37, 21.
[2]
Bellon, G. (1986) Pleuropulmonary Staphylococcal Disease in Infants. In: Gill, R. and Normand, J., Eds., Coord Pneumologie, Cardiologie, Paris, 21.
[3]
El Mamoun, T.B. (1991) Staphylococci in Children in the Infectious Diseases Department of the Children’s Hospital of Rabat. Abdelhamid Miri, Rabat.
[4]
Alpert, G., Campos, J.M., Harris, M.C., Preblud, S.R. and Plotkin, S.A. (1984) Vancomycin Dosage in Pediatrics Reconsidered. American Journal of Diseases of Children, 138, 20-22. https://doi.org/10.1001/archpedi.1984.02140390012005
[5]
Caffey, J. (1940) Regional Obstructive Pulmonary Emphysema in Infants and in Children. American Journal of Diseases of Children, 60, 586-605.
https://doi.org/10.1001/archpedi.1940.02000030118011
[6]
Jevons, M.P. (1961) “Celbenin”—Resistant Staphylococci. British Medical Journal, 1, Article No. 124. https://doi.org/10.1136/bmj.1.5219.124-a
[7]
Lepercq, G. and Leyne, M. (1972) Blowing during Pleuropulmonary Suppurations in Infants. Annals of Pediatrics, 19, 43-48.
[8]
Odio, C., McCracken Jr., G.H. and Nelson, J.D. (1984) Nephrotoxicity Associated with Vancomycln Aminoglycoside Therapy in Four Children. Journal of Pediatrics, 105, 491-493. https://doi.org/10.1016/S0022-3476(84)80036-0
[9]
Philips, M.R. and Milner, D.G. (1983) Clinical Pharmacology of Netilmicin in the Newborn. Archives of Disease in Childhood, 58, 451-453.
https://doi.org/10.1136/adc.58.6.451
[10]
Lacut, J.Y. and Dupon M. (1982) Antibiotic Treatment of Staphylococcal Infections. Revue du Praticien, 32, 3187-3199.
[11]
Pryles, C.V. (1958) Staphylococcal Pneumonia in Infancy and Childhood: An Analysis of 24 Cases. Pediatrics, 21, 609-623. https://doi.org/10.1542/peds.21.4.609
[12]
Chanal, M., Roussane, M.C., Miermont, C., Cluzel, M. and Sirot, D. (1980) Activité anti-bactérienne de la nétilmicine comparée avec d'autres aminosides. Médecine et Maladies Infectieuses, 10, 327-333. https://doi.org/10.1016/S0399-077X(80)80087-4
[13]
Chartrand, S.A. and McCracken Jr., G.H. (1982) Staphylococcal Pneumonia in Infants and Children. Pediatric Infectious Disease Journal, 1, 19-23.
https://doi.org/10.1097/00006454-198201000-00006
[14]
Parker, R.H. and Fossieck Jr., B.E. (1980) Intravenous Followed by Oral Antimicrobial Therapy for Staphylococcal Endocarditis. Annals of Internal Medicine, 93, 832-834. https://doi.org/10.7326/0003-4819-93-6-832
[15]
Craven, D.E., Reed, C., Kollisch, N., et al. (1981) A Large Outbreak of Infections Caused by a Strain of Staphylococcus aureus Resistant to Oxacillin and Aminoglycosides. The American Journal of Medicine, 71, 53-58.
https://doi.org/10.1016/0002-9343(81)90258-8
[16]
Estavoyer, J.M., Talon, D., Dupont, M.J., Bonin, P. and Michel-Briand, Y. (1984) Value of Rifampin in the Treatment of Staphylococcal Septicemia. Pathologie Biologie, 32, 552-555. (In French)
[17]
Estournet, B., Bataille, J. and Barois, A. (1985) Evolutiondes Infections Staphylococciques en Ranimation. Rea. Soins int. Med, 1, 53.
[18]
Fosse, T., et al. (1984) In Vitro Study of the Cefamandole-Fosfomycin Combination against Methicillin-Resistant Staphylococci. Pathologie Biologie, 32, 528-531. (In French)
[19]
Groff, D.B., Randolph, J.G. and Blades, B. (1984) Empyema in Childhood. JAMA, 195, 572-574. https://doi.org/10.1001/jama.195.7.572
[20]
Saint Martin, J. and Kachaner, J. (1969) Clinical Aspects and Therapeutic Possibilities of Severe Pleuropulmonary Staphylococci in Infants. Journées Parisiennes de Pédiatrie, 8, 275-299.
[21]
Lietman, P.S., Schaad, U.B., McCracken Jr., G.H. and Nelson, J.D. (1980) Clinical Pharmacology and Efficacy of Vancomycin in Pediatric Patients. The Journal of Pediatrics, 96, 119-126. https://doi.org/10.1016/S0022-3476(80)80347-7
[22]
Hendren, W.H. and Haggerty, R.J. (1958) Staphylococcal Pneumonia in Infancy and Childhood: Analysis of 75 Cases. JAMA, 168, 6-16.
https://doi.org/10.1001/jama.1958.03000010058003
[23]
Henricksson, P., Svenningsen, N., Juhlin, I. and Haeger, K. (1980) Netilmicin in Moderate to Severe Infections in Newborns and Infants: A Study of Tolerance, Efficacy and Pharmacokinetics. Scandinavian Journal of Infectious Diseases, 23, 155-159.
[24]
Hieber, J.P., Nelson, A.J. and McCracken Jr., G.H. (1977) Acuteisseminated Staphylococcal Disease in Childhood. American Journal of Diseases of Children, 131,181-185. https://doi.org/10.1001/archpedi.1977.02120150063012
[25]
Jarvis, W.R., Thornsberry, C., Hughes, J.M., Boyce, J. and Haley, R.W. (1984) Methicillin-Resistant Staphylococcus aureus at Children’s Hospitals in the United States. Pediatric Research, 18, 278.
https://doi.org/10.1203/00006450-198404001-01110
[26]
Sorrell, T.C. and Packham, D.R. (1982) Vancomycin therapy for Methicillin-Resistant Staphylococcus aureus. Annals of Internal Medicine, 97, 344-350. https://doi.org/10.7326/0003-4819-97-3-344
[27]
Kanoff, A., Kramer, B. and Carnes, M. (1939) Staphylococcus Pneumonia: A Clinical, Pathologic, and Bacteriologic Study. The Journal of Pediatrics, 14, 712-724.
https://doi.org/10.1016/S0022-3476(39)80091-9
[28]
Lepercq, G., Steinschneider, R., Saada, R. and Brocard, M. (1972) Pleuropulmonary Staphylococci in Infants. Normal Initial Radiological Aspects. Annals of Pediatrics, 19, 35-41.
[29]
Lamberz, J., Saint Martin, J., Lallemand, D. and Huault, G. (1971) Pleuro-Pulmonary Staphylococci of Acute Evolution of the Older Child. Pliatrie, 26, 13-30.
[30]
Maounis, F. and Niclopoulos, D. (1969) Staphylococcal Pneumonia in Infants. Lancet, 11, 268. https://doi.org/10.1016/S0140-6736(69)90033-6
[31]
McLaughlin, F.J., Goldmann, D.A., et al. (1984) Empyema in Children: Clinical Course and Long Term Follow-up. Pediatrics, 73, 587-593.
https://doi.org/10.1542/peds.73.5.587
[32]
Bingene, M.E. (1984) Introduction des dosages de traitement paramikacine desinfections sévèreset germes multiresistants chez le nourrisson et l’enfant. Société francaise de pediatrie, Editions Flammarion, Paris, 438
[33]
Miser, J.S. and Miser, A.W. (1980) Staphylococcus aureus Sepsis in Childhood Malignancy. American Journal of Diseases of Children, 134, 831-833.
https://doi.org/10.1001/archpedi.1980.02130210015005
[34]
Noel, G.J. and Edelson, P.J. (1984) Staphylococcus Epidermidis Bacteremia in Neonates: Further Observations and the Occurrence of Focal Infection. Pediatrics, 74, 832-837. https://doi.org/10.1542/peds.74.5.832
